XML 109 R88.htm IDEA: XBRL DOCUMENT v3.22.4
Supplementary Information to the Statements of Comprehensive Profit or Loss (Schedule of Research Expenses) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of transactions between related parties [abstract]      
Salary and benefits (including share-based compensation) [1] $ 4,494 $ 2,864 $ 2,701
Subcontractors 4,054 6,323 3,208
Depreciation and amortization 571 396 512
Cost of materials 572 347 922
Other research and development expenses 490 326 355
Total Research and development, net of participations $ 10,181 $ 10,256 $ 7,698
[1] The salary costs for the year ended December 31,2022 includes one time payment of $205 derived from termination agreement with the CMO of the company.